Angle (AGL)

 

Latest News

Professor to present webinar on use of ANGLE's Parsortix

ANGLE has announced that Professor Stuart Martin from the University of Maryland School of Medicine, USA, will be p...

WEBINAR:USING PARSORTIX TO TEST DRUGS ON LIVE CTCS

RNS Number: 9414B Angle PLC 16 January 2018 For immediate release 16 January 2018 ANGLE plc ("the Company") WEBINAR: USING THE PARSORTIX TM SYSTEM TO IDENTIFY DRUGS THAT MAY ARREST CANCER METASTASIS ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that Professor Stuart Marti...

Notice of Results

RNS Number: 4781B Angle PLC 10 January 2018 For Immediate Release 10 January 2018 ANGLE plc ("ANGLE" or "the Company") Notification of Interim Results and Webcast ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its interim results for the six months ended 31 October 2017 on Wednesday 31 January 201...

ANGLE reports new research on Parsortix

ANGLE said it was delighted to announce that the University Medical Centre Hamburg-Eppendorf together with the Med...

All News

DateHeadlineSource
16-01-18Professor to present webinar on use of ANGLE's Parsortix StockMarketWire
16-01-18WEBINAR:USING PARSORTIX TO TEST DRUGS ON LIVE CTCSRNS
10-01-18Notice of ResultsRNS
08-01-18ANGLE reports new research on Parsortix StockMarketWire
08-01-18ANGLE plc:Prostate cancer ARV7 treatment biomarkerRNS
27-12-17Holding(s) in CompanyRNS
12-12-17Transfer of Lock-in SharesRNS
08-12-17PARSORTIX POTENTIAL IN METASTATIC BREAST CANCERRNS
28-11-17Study shows out-performance of Parsortix, says ANGLEStockMarketWire
28-11-17Parsortix enables CTC molecular characterisationRNS
23-11-17ANGLE collaboration with Philips StockMarketWire
23-11-17PHILIPS COLLABORATION IN BREAST AND RECTAL CANCERRNS
17-11-17Holding(s) in CompanyRNS
16-11-17Total Voting Rights and Covington SubscriptionRNS
13-11-17Angle to present on 28 November 2017 at the Shares and AJ Bell Spotlight Evening in LondonStockMarketWire
06-11-17Holding(s) in CompanyRNS
06-11-17Holding(s) in CompanyRNS
06-11-17Holding(s) in CompanyRNS
02-11-17Holding(s) in CompanyRNS
01-11-17ANGLE completes Axela deal and fundraising StockMarketWire
01-11-17ANGLE: Completion of Fundraising and AcquisitionRNS
31-10-17All resolutions passed at AGM of AngleStockMarketWire
31-10-17Result of AGMRNS
30-10-17Angle shareholders approve resolutions at GMStockMarketWire
30-10-17Result of General MeetingRNS
26-10-17Total Voting RightsRNS
23-10-17ANGLE notes new report on Parsortix StockMarketWire
23-10-17Parsortix harvests cancer cells from bone marrowRNS
20-10-17Notice of AGMRNS
17-10-17ANGLE welcomes new peer review of Parsortix StockMarketWire
17-10-17ANGLE: 7th Peer Reviewed Publication On ParsortixRNS
12-10-17Proposed further subscription for ?2.8 millionRNS
09-10-17ANGLE's Parsortix showcased at CTC conferenceStockMarketWire
09-10-17CTCs harvested with Parsortix grown in laboratoryRNS
09-10-17Potential new analytical protocol using ParsortixRNS
09-10-17Parsortix Showcased at CTC ConferenceRNS
05-10-17ANGLE successfully raises £12.2m through various placingsStockMarketWire
05-10-17Results of FundraisingRNS
05-10-17ANGLE agrees Axela deal and raises £12.2mStockMarketWire
05-10-17Acquisition and FundraisingRNS

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account